2024 WCBA & ABCT Pitch Day
Hear from and network with founders of new healthcare ventures seeking to raise awareness, and/or secure funding, resources and partnerships. Attendees include investors, corporate sponsors and members of the life sciences ecosystem.
These 17 founders will pitch at the 2024 Pitch Day:
From WCBA:
Anita Lee (Independent) - Twin Weavers uses conversational and generative AI to assess, identify, and address health and social service needs throughout a person’s lifetime.
Ariel Yusupov (New York Medical College) - F.I.G Therapeutics: Their gene therapy, currently focused on prostate cancer, utilizes over-expressing factors in cancer to drive a multi-modal attack, designed to prevent resistance and more aggressive disease.
Daniel Gareau (Rockefeller University) - SurgiVance is advanced surgical pathology to drive better cancer care. Their diagnostic medical device will serve as a histopathology lab in a box to meet needs in pathology markets including specialty surgery.
Evris Gavathiotis (Albert Einstein College of Medicine) - Their technology encompasses a novel small molecule therapeutic strategy that exhibits broad efficacy in diverse cancers, aiming to advance to clinical stage.
Glen Prusky (Weill Cornell Medicine) - Gaze Engine: An efficient methodology to measure the visual contrast sensitivity function, which promises to replace visual acuity measures as the standard for routine vision assessment.
Hourinaz Behesti (Rockefeller University) Hebbian Bio is building a human stem cell-based technology platform for target discovery to develop first-in-class therapeutics for patients with currently untreatable neurodevelopmental/psychiatric disorders.
Ilya Popov (Independent) - ComeBack Mobility has developed a Smart Crutch Tips IoT device & mob apps that let patients know how to apply the right amount of force to the recovering limb + remote therapeutic monitoring service for providers.
Katia Rojas (Independent) - Suabix: Advanced AI for seamless integration of human factors and usability engineering, aligned with regulatory compliance, for safer, user-centered products in healthcare, MedTech and beyond.
Kirsten Hund Blair and Kevin McClarren (Independent) - Lambent Data’s collaborative and HIPAA-compliant software, including data analytics and AI, equips healthcare/social service providers and empowers patients/clients to improve outcomes in health and Social Drivers of Health and reduce healthcare costs.
Zach Sawaged (Independent) - Concordare is a suite of web-application tools that have an exclusive ability to read and write a novel digital clinical trial protocol called a CPTM.
From ABCT:
Courtney K. Rowe, Christopher Foster, and Kelly Burke (University of Connecticut) - Pallivex, a biodegradable implantable pain film to deliver targeted, sustained, opioid-free local anesthetics for postoperative pain control.
Joshua Gilmore (Independent) - Social Health Passport (SHP) is an end users and social service providers platform to share information and resources to support their client’s social mobility and self-sufficiency.
Julien Berro and Yuan Ren (Yale University) - Nanochuk: Biosensors for Force-Based Diagnostics and Therapeutics.
Ming Hui (Independent) - Mobabbi: First complete potty-training solution that teaches babies to use the potty at an earlier age using sound association.
Prisca Obi (Yale University) - Virtus Therapeutics is actively developing a new class of small- molecule activators for treatment of propionic acidemia, a rare metabolic disease.
Vanessa Sena and Helen Wu (Independent) - My Local Chefs integrates personalized medical nutrition therapy and innovative technology to enable faster decision- making for doctors, particularly in treating gestational diabetes in pregnant women, ultimately contributing to improved outcomes for both the mother and baby.
Due to limited space, all registrants will be screened by event organizers.
Disclaimer: By attending the 2024 ABCT and WCBA Pitch Day, you agree to grant FirstXFounder the use of any photos of your participation in this event. You further agree that any and all of the material photographed may be used in any form as part of marketing, publicity, and web content.